Skip to content
Recall Observatory FDA recall evidence

Drug product

Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.

D-0467-2024

April 09, 2024

Class III

Product summary

Firm
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Event
Event 94382
Status
Ongoing
Classification
Class III
Quantity
N/A
Official record key
drug-enforcement:D-0467-2024

Official wording

Reason: Cross Contamination with Other Products

Code information: Lot #: a) ALS00422A, Exp 04/30/2025; ALS00523A, Exp 11/30/2025; b) 1K77YUD1H1A, Exp 11/30/2024

Distribution pattern: USA nationwide.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Cross Contamination with Other Products